Skip to content

Concordance of Hypoglycemia Measurement With Simultaneous Use of Two Devices for Continuous Glucose Measurement.

Concordance of Hypoglycemia Measurement in People With Type 1 Diabetes, With Simultaneous Use of Two Devices for Continuous Glucose Measurement: Abbott Freestyle Libre 2 and Dexcom G7

Status
Suspended
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06246578
Enrollment
14
Registered
2024-02-07
Start date
2024-01-19
Completion date
2026-05-01
Last updated
2025-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoglycemia, Type 1 Diabetes

Keywords

Hypoglycemia, Continuous glucose monitoring, Dexcom, Libre, Blood glucose

Brief summary

The aim of this study is to compare two frequently used sensors for continuous glucose monitoring (CGM); Freestyle Libre and Dexcom G 7. More precisely, the investigators want to investigate if there is any difference in the hypoglycemic range for these two devices.

Detailed description

The investigators are including adults with type 1 diabetes who already are using a Dexcom G 7, in their diabetes treatment. Simultaneously with their Dexcom G7, the participants will get the Libre 2 sensor attached, and are to wear this for a period of 14 days. The Libre sensor is a Freetsyle Libre 2. Glucose data are compared for paired values within a time interval of 5 min or less. In this way the investigators have access to nearly simultaneous glucose values from two different CGM's. In addition, the participants are given a Contour Next One, and are asked to measure their blood glukose with fingerprick if their Dexcom registers a glucose value \< 5 mmol/l. By this project, we hope to gain more precise information about the two most widely distributed CGMs, and their function in the hypoglycemic area. This, can have impact on healthcare professionals' future therapeutic instructions, regarding the use of insulin adjustment and carbohydrate compensation.

Interventions

DEVICEContinuos glucose monitoring and blood glucose measurement

The individuals who use Dexcom G 7 sensors for continous glucose monitoring is in addition applied a Libre 2 sensor and asked to wear both sensors for 14 days. In case of a Dexcom glucose value \< 5 mmol/l, the participants is aked to measure a blood glucose as well uising fingerprick and Contour Next One

Sponsors

Central Jutland Regional Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Comparison of nearly simultaneous interstitial glucose values obtained by Dexcom G 7 and Libre 2 sensors for continuous glucose monitoring and blood glucose measured with Contour Next one

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

Type 1 diabetes Using Dexcom G 7 -

Exclusion criteria

Do not want to participate \-

Design outcomes

Primary

MeasureTime frameDescription
Difference between paired blood glucose values and simultaneous Dexcom and Libre glucose values5 minutes or less between the glucose values comparedDifference between paired blood glucose values and simultaneous CGM values for Dexcom and Libre for Dexcom values \< 5 mmol/l
Difference between paired Dexcom and Libre glucose values5 minutes or less between the glucose values comparedDifference between paired simultaneous CGM value for Dexcom and Libre for all measured glucose values.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026